Basic Information
| LncRNA/CircRNA Name | C5orf66-AS1 |
| Synonyms | C5orf66-AS1, CTC-276P9.1, Epist |
| Region | GRCh38_5:135038831-135040047 |
| Ensemble | ENSG00000249082 |
| Refseq | NR_105049 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | oral squamous cell carcinoma |
| ICD-0-3 | C06.9 |
| Methods | qPCR |
| Sample | oral squamous cell carcinoma tissues |
| Expression Pattern | differential expression |
| Function Description | Three lncRNAs in the validated list which showed the highest fold change (LOC441178, HCG22 and C5orf66-AS1) were verified by quantitative RT-PCR in a subset of 20 OSCCs and 10 control samples. |
| Pubmed ID | 28415559 |
| Year | 2017 |
| Title | Transcriptome analysis reveals differentially expressed lncRNAs between oral squamous cell carcinoma and healthy oral mucosa |
External Links
| Links for C5orf66-AS1 | GenBank HGNC NONCODE |
| Links for oral squamous cell carcinoma | OMIM COSMIC |